Table 1
Data sources and characteristics for this study.a
| TRAITS | YEAR | SOURCES | SAMPLE SIZE | POPULATION/SEX | NO. OF SUITABLE IVS | F STATISTICS |
|---|---|---|---|---|---|---|
| C-reactiveprotein | 2018 | PMID: 30388399Ligthart et al. | 204,402 | European/Both | 110 | 41.771 |
| Interleukin-1α | 2018 | PMID: 29875488Sun et al. | 3,301 | European/Both | 10 | 10.251 |
| Interleukin-1β | 2018 | PMID: 29875488Sun et al. | 3,301 | European/Both | 9 | 10.461 |
| Interleukin-6 | 2020 | PMID: 33067605Folkersen et al. | 21,758 | European/Both | 15 | 12.016 |
| Interleukin-10 | 2016 | PMID: 27989323Ahola-Olli et al. | 7,681 | European/Both | 12 | 15.418 |
| Interleukin-18 | 2020 | PMID: 33067605Folkersen et al. | 21,758 | European/Both | 24 | 20.058 |
| Neutrophilcount | 2020 | BCCVuckovic et al. | 563,946 | European/Both | 572 | 31.443 |
| Lymphocytecount | 2020 | BCCVuckovic et al. | 563,946 | European/Both | 670 | 32.688 |
| Monocytecout | 2020 | BCCVuckovic et al. | 563,946 | European/Both | 653 | 45.533 |
| Acute myocardialinfarction | 2022 | FinnGenKurki et al. | 307,230 | European/Both | 102 | 11.499 |
[i] a BCC = Blood Cell Consortium; IV = Instrumental variable.
Table 2
Effect of inflammatory factors and inflammatory cells on the risk of acute myocardial infarction.a
| EXPOSURES | METHODS | OR (95%CI) | P VALUEb | P VALUEc | P VALUEd |
|---|---|---|---|---|---|
| C-reactiveprotein | IVW | 0.972 (0.896 ~ 1.055) | 0.504 | 0.027 | 0.298 |
| Weighted median | 0.947 (0.842 ~ 1.066) | 0.367 | |||
| MR-Egger | 0.920 (0.805 ~ 1.050) | 0.220 | |||
| Interleukin-1α | IVW | 1.008 (0.927 ~ 1.095) | 0.857 | 0.301 | 0.121 |
| Weighted median | 0.978 (0.885 ~ 1.080) | 0.660 | |||
| MR-Egger | 0.353 (0.124 ~ 1.009) | 0.124 | |||
| Interleukin-1β | IVW | 0.996 (0.901 ~ 1.101) | 0.938 | 0.092 | 0.226 |
| Weighted median | 1.009 (0.910 ~ 1.119) | 0.867 | |||
| MR-Egger | 1.359 (0.866 ~ 2.132) | 0.239 | |||
| Interleukin-6 | IVW | 0.991 (0.888 ~ 1.106) | 0.875 | 0.477 | 0.234 |
| Weighted median | 0.954 (0.826 ~ 1.102) | 0.522 | |||
| MR-Egger | 1.148 (0.895 ~ 1.473) | 0.309 | |||
| Interleukin-10 | IVW | 0.876 (0.788 ~ 0.974) | 0.015 | 0.171 | 0.390 |
| Weighted median | 0.868 (0.767 ~ 0.981) | 0.024 | |||
| MR-Egger | 1.265 (0.572 ~ 2.798) | 0.579 | |||
| Interleukin-18 | IVW | 0.934 (0.875 ~ 0.997) | 0.040 | 0.603 | 0.503 |
| Weighted median | 0.916 (0.840 ~ 0.998) | 0.045 | |||
| MR-Egger | 0.898 (0.787 ~ 1.024) | 0.125 | |||
| Neutrophilcount | IVW | 1.022 (0.952 ~ 1.097) | 0.549 | 0.063 | 0.352 |
| Weighted median | 1.053 (0.950 ~ 1.167) | 0.325 | |||
| MR-Egger | 1.099 (0.928 ~ 1.303) | 0.273 | |||
| Lymphocytecount | IVW | 1.060 (0.992 ~ 1.131) | 0.084 | 0.072 | 0.731 |
| Weighted median | 1.029 (0.930 ~ 1.139) | 0.580 | |||
| MR-Egger | 1.084 (0.936 ~ 1.255) | 0.280 | |||
| Monocytecout | IVW | 1.047 (0.992 ~ 1.106) | 0.095 | 0.063 | 0.062 |
| Weighted median | 1.023 (0.929 ~ 1.127) | 0.643 | |||
| MR-Egger | 0.969 (0.879 ~ 1.069) | 0.531 |
[i] a IVW = Inverse variance weighted; OR = Odds ratio; CI = Confidence interval.
b P value for Mendelian randomization.
c P value for Cochran’s Q test.
d P value for MR-Egger intercept test.

Figure 1
Effect of peripheral interleukin-10 and interleukin 18 on the risk of acute myocardial infarction. IVW = Inverse variance weighted; MR = Mendelian randomization; SNP = Single nucleotide polymorphism.
Table 3
Effect of acute myocardial infarction on periphery levels of inflammatory factors and inflammatory cells.a
| OUTCOMES | METHODS | OR (95%CI) | P VALUEb | P VALUEc | P VALUEd |
|---|---|---|---|---|---|
| C-reactiveprotein | IVW | 1.004 (0.982 ~ 1.026) | 0.739 | 0.146 | 0.097 |
| Weighted median | 0.976 (0.949 ~ 1.004) | 0.093 | |||
| MR-Egger | 0.955 (0.898 ~ 1.015) | 0.147 | |||
| Interleukin-1α | IVW | 1.009 (0.927 ~ 1.097) | 0.844 | 0.118 | 0.782 |
| Weighted median | 0.931 (0.824 ~ 1.051) | 0.248 | |||
| MR-Egger | 1.037 (0.837 ~ 1.285) | 0.740 | |||
| Interleukin-1β | IVW | 0.941 (0.870 ~ 1.017) | 0.122 | 0.553 | 0.665 |
| Weighted median | 0.888 (0.789 ~ 1.001) | 0.052 | |||
| MR-Egger | 0.979 (0.805 ~ 1.191) | 0.833 | |||
| Interleukin-6 | IVW | 0.992 (0.954 ~ 1.031) | 0.671 | 0.500 | 0.401 |
| Weighted median | 0.996 (0.934 ~ 1.062) | 0.906 | |||
| MR-Egger | 0.954 (0.865 ~ 1.052) | 0.348 | |||
| Interleukin-10 | IVW | 1.062 (1.003 ~ 1.124) | 0.040 | 0.404 | 0.961 |
| Weighted median | 1.008 (0.925 ~ 1.099) | 0.848 | |||
| MR-Egger | 1.058 (0.917 ~ 1.221) | 0.440 | |||
| Interleukin-18 | IVW | 0.979 (0.943 ~ 1.015) | 0.250 | 0.058 | 0.148 |
| Weighted median | 0.961 (0.913 ~ 1.012) | 0.134 | |||
| MR-Egger | 0.919 (0.838 ~ 1.008) | 0.075 | |||
| Neutrophilcount | IVW | 0.995 (0.987 ~ 1.003) | 0.244 | 0.054 | 0.252 |
| Weighted median | 0.989 (0.978 ~ 1.002) | 0.088 | |||
| MR-Egger | 0.985 (0.967 ~ 1.004) | 0.127 | |||
| Lymphocytecount | IVW | 0.993 (0.985 ~ 1.001) | 0.083 | 0.153 | 0.455 |
| Weighted median | 0.982 (0.970 ~ 0.994) | 0.003 | |||
| MR-Egger | 0.987 (0.969 ~ 1.005) | 0.155 | |||
| Monocytecout | IVW | 1.000 (0.991 ~ 1.009) | 0.995 | 0.149 | 0.835 |
| Weighted median | 0.994 (0.981 ~ 1.007) | 0.356 | |||
| MR-Egger | 0.998 (0.978 ~ 1.019) | 0.853 |
[i] a IVW = Inverse variance weighted; OR = Odds ratio; CI = Confidence interval.
b P value for Mendelian randomization.
c P value for Cochran’s Q test.
d P value for MR-Egger intercept test.
Table 4
MR-PRESSO results for Mendelian randomization analyses and outlier tests.a
| EXPOSURES | β VALUE | SD | OR (95%CI) | P VALUE FOR MR | P VALUE FOR OUTLIERS |
|---|---|---|---|---|---|
| C-reactive protein | –0.028 | 0.042 | 0.972 (0.896 ~ 1.056) | 0.506 | 0.032 |
| Interleukin-1α | 0.008 | 0.042 | 1.008 (0.928 ~ 1.095) | 0.864 | 0.342 |
| Interleukin-1β | –0.004 | 0.051 | 0.996 (0.901 ~ 1.101) | 0.941 | 0.124 |
| Interleukin-6 | –0.009 | 0.055 | 0.991 (0.890 ~ 1.104) | 0.875 | 0.498 |
| Interleukin-10 | –0.132 | 0.054 | 0.876 (0.788 ~ 0.974) | 0.041 | 0.229 |
| Interleukin-18 | –0.068 | 0.031 | 0.934 (0.879 ~ 0.993) | 0.042 | 0.665 |
| Neutrophil count | 0.022 | 0.036 | 1.022 (0.953 ~ 1.097) | 0.550 | 0.064 |
| Lymphocyte count | 0.058 | 0.033 | 1.060 (0.993 ~ 1.131) | 0.084 | 0.076 |
| Monocyte cout | 0.046 | 0.028 | 1.047 (0.991 ~ 1.106) | 0.096 | 0.070 |
| OUTCOMES | β VALUE | SD | OR (95%CI) | P VALUE FOR MR | P VALUE FOR OUTLIERS |
| C-reactive protein | 0.004 | 0.011 | 1.004 (0.983 ~ 1.026) | 0.741 | 0.145 |
| Interleukin-1α | 0.008 | 0.043 | 1.008 (0.927 ~ 1.097) | 0.844 | 0.116 |
| Interleukin-1β | –0.061 | 0.039 | 0.941 (0.872 ~ 1.016) | 0.121 | 0.567 |
| Interleukin-6 | –0.008 | 0.020 | 0.992 (0.954 ~ 1.032) | 0.671 | 0.500 |
| Interleukin-10 | 0.060 | 0.029 | 1.062 (1.003 ~ 1.124) | 0.044 | 0.418 |
| Interleukin-18 | –0.022 | 0.019 | 0.978 (0.942 ~ 1.015) | 0.253 | 0.057 |
| Neutrophil count | –0.005 | 0.004 | 0.995 (0.987 ~ 1.003) | 0.249 | 0.053 |
| Lymphocyte count | –0.007 | 0.004 | 0.993 (0.985 ~ 1.001) | 0.089 | 0.138 |
| Monocyte cout | 2.733e-05 | 0.004 | 1.000 (0.992 ~ 1.008) | 0.995 | 0.138 |
[i] a SD = Standard deviation; OR = Odds ratio; CI = Confidence interval; MR = Mendelian randomization.

Figure 2
Effect of acute myocardial infarction on peripheral interleukin-10 and lymphocyte count. IVW = Inverse variance weighted; MR = Mendelian randomization; SNP = Single nucleotide polymorphism.
